FOXA1: a Promising Prognostic Marker in Breast Cancer
نویسندگان
چکیده
منابع مشابه
FOXA1: a promising prognostic marker in breast cancer.
Accurate diagnosis and proper monitoring of cancer patients remain important obstacles for successful cancer treatment. The search for cancer biomarkers can aid in more accurate prediction of clinical outcome and may also reveal novel predictive factors and therapeutic targets. One such prognostic marker seems to be FOXA1. Many studies have shown that FOXA1 is strongly expressed in a vast major...
متن کاملMammaglobin a: a promising marker for breast cancer.
prognosis better than approaches using immunohistochemistry or fluorescence in situ hybridization (14 ). Increased serum HER-2/neu was detected in 12% of an overall breast cancer group (15 ) and provided independent prognostic information (12 ) that was superior to that from nodal involvement or hormone receptor status (15 ). Preoperative HER-2/neu concentrations in sera are significantly assoc...
متن کاملFoxo3a Expression Is a Prognostic Marker in Breast Cancer
The forkhead box transcription factor Foxo3a has been implicated to play a critical role in various cancers by suppressing tumor growth. Recent studies have identified Foxo3a as a key regulator of Estrogen Receptor-α (ERα). In the present study, we examined the expression of Foxo3a, and investigated its clinical significance and correlation with ER and prognostic role in patients with breast ca...
متن کاملCD24 expression is a new prognostic marker in breast cancer.
PURPOSE CD24 is expressed in hematological malignancies as well as in a large variety of solid tumors including breast cancer. We aimed to evaluate CD24 protein expression in breast cancer and to correlate to clinicopathological data including patient survival. EXPERIMENTAL DESIGN Primary breast carcinomas (201) with a mean clinical follow-up time of 53 months were immunostained using a monoc...
متن کاملp53 expression as a prognostic marker in inflammatory breast cancer.
PURPOSE Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer. Nuclear expression of p53 protein in breast cancer correlates with more aggressive tumors. We retrospectively analyze the expression of p53 as a prognostic marker to predict pathological complete response and survival in patients with IBC. EXPERIMENTAL DESIGN Fifty-nine patients with IBC were treated from...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Asian Pacific Journal of Cancer Prevention
سال: 2014
ISSN: 1513-7368
DOI: 10.7314/apjcp.2014.15.1.11